Joseph R. Mikhael, M.D.
Mayo Clinic
3
2
3
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+2 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Shaji Kumar, M.D.
Mayo Clinic
Shared therapeutic areas:
Worked with same sponsors:
Martha Lacy, M.D.
Mayo Clinic
Shared therapeutic areas:
Worked with same sponsors:
Vivek Roy, M.D.
Mayo Clinic
Shared therapeutic areas:
Worked with same sponsors:
David Avigan, MD
Beth Israel Deaconess Medical Center
Shared therapeutic areas:
Worked with same sponsors:
PEGOURIE, MD
University Hospital, Grenoble
Shared therapeutic areas:
Michel ATTAL, MD, PhD
University Hospital, Toulouse
Shared therapeutic areas:
AUGEL MEUNIER, MD
CHU ST PRIEST EN JAREZ
Shared therapeutic areas:
MOREL, MD
Hôpital la Pitié Salpêtrière Paris
Shared therapeutic areas:
BENBRAHIM, MD
CH ORLEANS
Shared therapeutic areas:
Areej El-Jawahri, MD
Massachusetts General Hospital
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
Pomalidomide, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Plerixafor in Treating Patients With Multiple Myeloma Previously Treated With Lenalidomide and Planning to Undergo Autologous Stem Cell Transplant
Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma
All 3 trials loaded